Kurum Yazarı "Sakin, Abdullah" WoS İndeksli Yayınlar Koleksiyonu İçin Listeleme
-
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024)
Şenocak Taşçı, Elif; Oyan, Başak; Sönmez, Özlem; Mutlu, Arda Ulaş; Atçı, Muhammed Mustafa; Sakin, Abdullah; Öner, İrem; Yeşil Çınkır, Havva; Bozkurt, Mustafa (BMC, 2024)... -
Effect of taxifolin on doxorubicin-induced oxidative cardiac damage in rats: A biochemical and histopathological evaluation
Aldemir, Mehmet Naci; Kara, Ali Veysel; Mammadov, Renad; Yazıcı, Gülce Naz; Çiçek, Betül; Yavuzer, B.; Coşkun, Reşit; Sakin, Abdullah; Gülaboğlu, Mine; Süleyman, Halis (Pakistan Agricultural Scientists Forum, 2024)Doxorubicin is a widely used anthracycline-derived broad-spectrum antitumoral antibiotic drug. However, cardiotoxicity due to doxorubicin treatment has warranted dose reduction or complete discontinuation in certain cases. ... -
Efficacy of capecitabine and temozolomide regimen in neuroendocrine tumors: Data from the Turkish oncology group
Ünal, Çağlar; Azizy, Abdulmunir; Karabulut, Senem; Taştekin, Didem; Akyıldız, Arif; Yaşar, Serkan; Yalçın, Şuayib; Çoban, Eyüp; Evrensel, Türkkan; Kalkan, Ziya; Sağlam, Sezer (Oxford University Press, 2023)Introduction: This study aims to report the efficacy and safety of capecitabine plus temozolomide (CAPTEM) across different lines of treatment in patients with metastatic neuroendocrine tumors (NETs).Methods: We conducted ... -
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
Karacin, Cengiz; Öksüzoğlu, Berna; Demirci, Ayşe; Keskinkılıç, Merve; Baytemür, Naziyet Köse; Yılmaz, Funda; Selvi, Oğuzhan; Erdem, Dilek; Avşar, Esin; Paksoy, Nail; Demir, Necla; Göksu, Sema Sezgin; Türker, Sema; Bayram, Ertuğrul; Çelebi, Abdüssamet; Yılmaz, Hatice; Kuzu, Ömer Faruk; Kahraman, Seda; Gökmen, İvo; Sakin, Abdullah (BioMed Central Ltd, 2023)Background: There is no standard treatment recommended at category 1 level in international guidelines for subsequent therapy after cyclin-dependent kinase 4/6 inhibitor (CDK4/6) based therapy. We aimed to evaluate which ... -
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023)
Karacin, Cengiz; Öksüzoğlu, Berna; Demirci, Ayşe; Keskinkılıç, Merve; Köse Baytemur, Naziyet; Yılmaz, Funda; Selvi, Oğuzhan; Hacıbekiroğlu, İlhan (BMC, 2023)Following publication of the original article [1], the authors reported an error in the author name of Enes Erul. -
Factors affecting survival in operated gastric cancer
Sakin, Ayşegül; Şahin, Süleyman; Sakin, Abdullah; Aldemir, Mehmet Naci; Sakoğlu, Nevin; Bayram, İrfan; Kotan, Mehmet Çetin (Elsevier Ltd, 2023)In this study, our aim was to determine the possible effects of Helicobacter pylori (HP), chronic atrophic gastritis (CAG), and gastrointestinal metaplasia (GIM) on survival in operated bowel type gastric cancer patients ... -
A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy
Kılıçkap, Saadettin; Öztürk, Akın; Karadurmuş, Nuri; Korkmaz, Taner; Yumuk, Perran Fulden; Çiçin, İrfan; Paydaş, Semra; Çılbır, Ebru; Şakalar, Teoman; Uysal, Mükremin; Yeşil Çınkır, Havva; Üskent, Necdet; Demir, Necla; Sakin, Abdullah; Dursun, Oldaç Uras; Aver, Birkan; Turhal, Nazım Serdar; Keskin, Serkan; Tural, Deniz; Eralp, Yeşim; Buğdaycı Başal, Fatma; Yaşar, Hatime Arzu; Şendur, Mehmet Ali Nahit; Demirci, Umut; Çubukçu, Erdem; Karaağaç, Mustafa; Çakar, Burcu; Tatlı, Ali Murat; Yetişyiğit, Tarkan; Urvay, Semiha; Gürsoy, Pınar; Oyan, Başak; Turna, Zeynep Hande; Işıkdoğan, Abdurrahman; Ölmez, Ömer Fatih; Yazıcı, Ozan; Çabuk, Devrim; Şeker, Mehmet Metin; Ünal, Olçun Ümit; Meydan, Nezih; Okutur, Sadi Kerem; Tunalı, Didem; Erman, Mustafa (2024)To evaluate radiological and clinical features in metastatic anaplastic lymphoma kinase+ non-small cell lung cancer patients and crizotinib efficacy in different lines. This national, non-interventional, multicenter, ... -
The prognostic effect of pretreatment 18F-FDG PET/CT metabolic parameters in locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
Sakin, Abdullah; Özçelik, Mahsun; Şahin, Süleyman; Aydemir, Ozan; Aldemir, Mehmet Naci; İliklerden, Ümit Haluk; Kotan, Mehmet Çetin (Elsevier Science Ltd, 2022)Introduction: In this study, we aimed to examine the relation between pre-treatment 18F-FDG PET/CT metabolic parameters [(including the maximum standard uptake value (SUVmax), metabolic tumor volume (MTV), and tumor lesion ... -
Real-world efficacy and safety of first-line nivolumab plus chemotherapy in patients with advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: A nationwide observational Turkish Oncology Group (TOG) study
Kutlu, Yasin; Dae, Shute Ailia; Yılmaz, Feride; Erdem, Dilek; Şendur, Mehmet Ali Nahit; Akbaş, Sinem; Şenocak Taşçı, Elif; Baş, Onur; Dane, Faysal; Sakin, Abdullah; Kaya, Ali Osman; Aykan, Musa Barış; Ergün, Yakup; Biter, Sedat; Dişel, Umut; Korkmaz, Mustafa; Selçukbiricik, Fatih; Köse, Fatih; Ölmez, Ömer Fatih; Bilici, Ahmet; Demir, Gökhan; Yalçın, Şuayib (2024)Based on the CheckMate 649 trial, nivolumab plus chemotherapy is the recommended first-line treatment for HER2-negative unresectable advanced or metastatic gastric, gastroesophageal junction (GEJ), or esophageal adenocarcinoma. ... -
Role of consolidative stereotactic body radiation therapy in oligoresistant/oligoprogressive pulmonary parenchymal metastases
Berber, Tanju; Sakin, Abdullah (Dove Medical Press Ltd, 2022)Aim: To extend the survival of patients by providing local control of metastases in oligoresistance/oligoprogressive disease. Methods: We retrospectively evaluated the efficacy of stereotactic body radiotherapy (SBRT) ...